This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Raqualia Pharma Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Akiyoshi Fujiuchi: Innovator in Dementia Treatment
Introduction
Akiyoshi Fujiuchi is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dementia. His innovative work has led to the development of a unique compound that holds promise for improving the lives of those affected by this condition.
Latest Patents
Akiyoshi Fujiuchi holds a patent for "5-HT4 receptor agonists for the treatment of dementia." This invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof with 5-HT4 agonistic activities, which is useful in the treatment of dementia. The patent also includes a pharmaceutical composition for the treatment of dementia that comprises a therapeutically effective amount of the compound. Furthermore, it outlines a method for treating dementia in an animal subject, including mammals, by administering the compound.
Career Highlights
Throughout his career, Akiyoshi Fujiuchi has worked with various companies, including Raqualia Pharma Inc. and Askat Inc. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Akiyoshi has collaborated with notable colleagues such as Yukinori Take and Hiroyuki Ohshiro. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Akiyoshi Fujiuchi is a distinguished inventor whose work in developing treatments for dementia showcases his commitment to advancing medical science. His innovative patent and collaborations reflect his significant contributions to the field.